Concepedia

Teja Devarakonda

TD

7

Publications

316

Citations

7

H-Index

2016

Active since

Affiliations

Virginia Commonwealth University(Current)

Teja Devarakonda is an author at Virginia Commonwealth University specializing in cardiovascular disease, medicine, and cardiovascular pharmacology.

Top concepts

Publications per year

2016–2024

7

Publications

7

Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism

Juan Valle Raleigh, Adolfo G Mauro, Teja Devarakonda et al. · Cardiovascular Research · 2016 · 96 citations · Full text

Functional analysis of molecular and pharmacological modulators of mitochondrial fatty acid oxidation

Yibao Ma, Wei Wang, Teja Devarakonda et al. · Scientific Reports · 2020 · 78 citations · Full text

Sacubitril/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits

Juan Torrado, Chad Cain, Adolfo G Mauro et al. · Journal of the American College of Cardiology · 2018 · 73 citations

, , +6

Remote Ischemic Pre-Conditioning Attenuates Adverse Cardiac Remodeling and Mortality Following Doxorubicin Administration in Mice

Zachary M. Gertz, Chad Cain, Donatas Kraskauskas et al. · JACC CardioOncology · 2019 · 23 citations · Full text

B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice

Teja Devarakonda, Adolfo G Mauro, Geronimo Guzman et al. · Journal of the American Heart Association · 2020 · 19 citations · Full text

Rows per page

1–5 of 7